---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-25-000562"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T17:13:12.631908+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Renovaro completes acquisition of Biosymetrics, issues 15M shares

## Summary
- Consummated merger with Biosymetrics on April 8, 2025; Biosymetrics becomes wholly owned subsidiary.
- Issued 15.0 million shares of Renovaro common stock to former Biosymetrics stockholders.
- Shares issued in reliance on Section 4(a)(2) exemption based on accredited investor representations.
- Transaction was previously announced on February 26, 2025 via Merger Agreement.

## SEC filing metadata
- accession: 0001731122-25-000562
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112225000562/0001731122-25-000562-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112225000562/e6512_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-25-000562
- JSON: https://secwatch.observer/filing/0001731122-25-000562.json
- Plain text: https://secwatch.observer/filing/0001731122-25-000562.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.